A METHOD FOR THE ESTABLISHMENT OF A PLURIPOTENT HUMAN BLASTOCYST-DERIVED STEM CELL LINE

Details for Australian Patent Application No. 2002367091 (hide)

Owner CELL THERAPEUTICS SCANDINAVIA AB

Inventors SEMB, Henrik; TONNING, Anna

Pub. Number AU-A-2002367091

PCT Number PCT/EP02/14895

PCT Pub. Number WO2003/055992

Priority 0104471-8 28.12.01 SE; 60/342,771 28.12.01 US

Filing date 27 December 2002

Wipo publication date 15 July 2003

International Classifications

C12N 005/08 Undifferentiated human, animal or plant cells, e.g. cell lines -

A61P 005/48 Drugs for disorders of the endocrine system

A61P 025/28 Drugs for disorders of the nervous system

A61K 035/54 Medicinal preparations containing material or reaction products thereof with undetermined constitution

Event Publications

4 September 2003 Application Open to Public Inspection

  Published as AU-A-2002367091

4 September 2003 Complete Application Filed

  Priority application(s): 0104471-8 28.12.01 SE; 60/342,771 28.12.01 US

14 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002367092-NOVEL COMPOUNDS

2002367090-Pyrrolopyrimidines as phosphodiesterase VII inhibitors